MedTrace Logo

Holter of Movement in Patients With Amyotrophic Lateral Sclerosis.

NCT06228001 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2025-05-19

No results posted yet for this study

Summary

ActiALS is a multicentric academic study. Patients with amyotrophic lateral sclerosis (ALS) may be included on a voluntary basis. The investigators plan to include a group of approximately 30 patients with ALS.

The investigators have planned to assess patient every three months for a year. After each visit, participants will wear Actimyo for one month daily.

Conditions

Interventions

DEVICE

Actimyo

Actimyo is an innovative device intended to be used in a home-based environment. It is composed of two watch-like sensors, each containing a magneto-inertial sensors that record the linear acceleration, the angular velocity, the magnetic field of the movement in all directions.The two watches can be worn as wristwatch or placed near the ankle.

Sponsors & Collaborators

  • SYSNAV

    collaborator INDUSTRY

  • Centre Hospitalier Universitaire de Liege

    lead OTHER

Principal Investigators

  • Stéphanie Delstanche, MD · Centre de référence des maladies neuromusculaire, Centre Hospitalier Régional de la Citadelle

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2028-01-31
Completion
2028-01-31
FDA Device
Yes

Countries

  • Belgium
  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06228001 on ClinicalTrials.gov